- Home
- SPRY vs EXPI Comparison
SPRY vs EXPI Comparison
Compare SPRY & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- EXPI
- Stock Information
- Founded
- SPRY 2015
- EXPI 2008
- Country
- SPRY United States
- EXPI United States
- Employees
- SPRY N/A
- EXPI N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- EXPI Real Estate
- Sector
- SPRY Health Care
- EXPI Finance
- Exchange
- SPRY Nasdaq
- EXPI Nasdaq
- Market Cap
- SPRY 1.4B
- EXPI 1.3B
- IPO Year
- SPRY N/A
- EXPI N/A
- Fundamental
- Price
- SPRY $14.16
- EXPI $8.20
- Analyst Decision
- SPRY Strong Buy
- EXPI Buy
- Analyst Count
- SPRY 4
- EXPI 2
- Target Price
- SPRY $28.75
- EXPI $10.75
- AVG Volume (30 Days)
- SPRY 1.5M
- EXPI 1.5M
- Earning Date
- SPRY 05-14-2025
- EXPI 05-06-2025
- Dividend Yield
- SPRY N/A
- EXPI 2.35%
- EPS Growth
- SPRY N/A
- EXPI N/A
- EPS
- SPRY N/A
- EXPI N/A
- Revenue
- SPRY $97,122,000.00
- EXPI $4,579,524,000.00
- Revenue This Year
- SPRY $1.49
- EXPI $4.98
- Revenue Next Year
- SPRY $141.68
- EXPI $9.47
- P/E Ratio
- SPRY N/A
- EXPI N/A
- Revenue Growth
- SPRY 971120.00
- EXPI 4.83
- 52 Week Low
- SPRY $7.55
- EXPI $6.90
- 52 Week High
- SPRY $18.51
- EXPI $15.39
- Technical
- Relative Strength Index (RSI)
- SPRY 50.86
- EXPI 48.81
- Support Level
- SPRY $14.32
- EXPI $7.48
- Resistance Level
- SPRY $15.50
- EXPI $9.32
- Average True Range (ATR)
- SPRY 0.84
- EXPI 0.30
- MACD
- SPRY 0.06
- EXPI 0.12
- Stochastic Oscillator
- SPRY 65.19
- EXPI 39.30
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About EXPI eXp World Holdings Inc.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.